Patent protection for human genes ends in the US

In Myriad the Supreme Court excludednaturally occurring DNA, such as genes,from the scope of patent protection. It isnot yet clear what impact the decisionwill have and that very uncertainty isfuelling concern throughout the medicaland biotech industries


Unlock unlimited access to all IAM content